Who invested in GreenLigh Biosciences?
GreenLigh Biosciences's investors include Alexandria Real Estate Equities, Baird Capital, S2G Ventures, Tao Capital and Blue I/O/ Continental Grain.
United States · Funded startup
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2019, from 1 source
Reported by FinSMEs
GreenLigh Biosciences's investors include Alexandria Real Estate Equities, Baird Capital, S2G Ventures, Tao Capital and Blue I/O/ Continental Grain.
GreenLigh Biosciences has raised $50M across 1 round since 2019.
GreenLigh Biosciences's most recent round was an Undisclosed round of $50M in Jan 2019.
Its most recent round, $50M in Jan 2019, is also its largest on record.
GreenLigh Biosciences's first round on record, in Jan 2019, was backed by Alexandria Real Estate Equities, Baird Capital and S2G Ventures and 2 others.
GreenLigh Biosciences's latest named round is an Undisclosed round, in Jan 2019.
GreenLigh Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.